Trial
NCT02586831
Diabetes Islet Preservation Immune Treatment
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Camillo Ricordi and Jay Skyler
Collaborators
Diabetes Research Institute Foundation
Condition
Diabetes Mellitus, Type 1
Intervention
Anti-Thymocyte Globulin (ATG)
Why stopped
Study withdrawn prior to enrollment due to funding issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-15